Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Polycystic Ovary Syndrome 2Lymphoma, Non-Hodgkin 2Leukemia, Myeloid, Acute 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Renal Insufficiency 1Pancreatic Neoplasms 1Neoplasms, Adipose Tissue 1Myelodysplastic Syndromes 1Multiple Endocrine Neoplasia Type 1 1Lymphoma, Follicular 1Kidney Failure, Chronic 1Diabetes Mellitus, Type 2 1Body Weight 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Kidney Transplantation 2peginesatide 1hematide 1carfilzomib 1Sitagliptin Phosphate 1Palliative Care 1Massage 1Mass Screening 1Duration of Therapy 1Cyclosporine 1Cyclophosphamide 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Kidney Failure, Chronic × Sitagliptin Phosphate × Clear all
NCT00418366 2015-08-19

A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)

Merck Sharp & Dohme LLC

Phase 1 Completed
24 enrolled
GenitourinaryLymphoid

Kidney Failure, Chronic, Lymphoma, Follicular, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡